CasNo.51-21-8,qualified of 5-Fluorouracil pharmaceutical intermediate 51-21-8 china,(51-21-8) Suppliers

1 Kilogram	Negotiable

Min.Order :1 Kilogram
Purity: 99.0%min
Payment Terms : T/T

Keywords

pharmaceutical intermediate 51-21-8 qualified of 5-Fluorouracil 5-Fluorouracil china

Quick Details

Appearance:White powder
Application:Anti tumor drug. For a variety of cancers such as gastrointestinal cancer, breast cancer, ovarian cancer, chorionic epithelial cancer, cervical cancer, liver cancer, bladder cancer, skin cancer (topic
PackAge:25kg firber drum
ProductionCapacity:5|Metric Ton|Day
Storage:dry and cool place
Transportation:by sea or air

Superiority:

Our Advantage:

Prompt reply, Fast shipment,

Competitive price, First class after-sale services

Professional manufacturer, Raw materials from origin

Over the years, the company adhere to market-oriented, technology and development, quality of life for the purpose. Strengthening enterprise management, has a high quality, the ability to develop strong and rich experience in the production of professional and technical teams. Production of advanced technology, sophisticated equipment, means of improving detection.

Our products are exported to the United States, European Union, Southeast Asia and other countries and regions. Users both here and abroad and has established long-term and stable supplier relations, occupies a stable market share and to maintain sustained growth. And with domestic and foreign universities, research institutes and some well-known companies have extensive cooperation and close ties.

We follow the "quality and integrity" business philosophy, For Chinese and foreign customers to provide quality products and services in order to do long-term win-win business, and seek common development. We sincerely welcome friends from all over the world to exchange and cooperation!

Details:

Specifications

5-Fluorouracil have high quality and competitive prices
51-21-8 in stock
We are factory and manufacturer

CAS NO.	51-21-8
Product Name	5-Fluorouracil
Synonyms	Ro-2-9757; Phtoruracil; Ulup; 2,4(1H,3H)-Pyrimidinedione,5-fluoro-; Phthoruracil; Uracil, 5-fluoro-; 5-Fluoro-2,4(1H, 3H)-pyrimidinedione; 2,4 (1H, 3H)-Pyrimidinedione, 5-fluoro-; 5-Fluoro-2,4(1H,3H)-pyrimidinedione; Fluoroplex; 5-Fluoracyl; Efudex; Effluderm (free base); 5-Ftouracyl; 5-Fluoropyrimidine-2,4-dione;
Structure
Purity	99%
Molecular Formula	C₄H₃FN₂O₂
Molecular Weight	130.0772
Flash Point	196.5 °C
Refractive index	1.542
InChI	InChI=1S/C4H3FN2O2/c5-2-1-6-4(9)7-3(2)8/h1H,(H2,6,7,8,9)
Boiling Point	401.4 °C at 760 mmHg
Density	1.53 g/cm3
Melting Point	278-286℃
Storage Temperature	Store at 0-5℃

Introduction:

Fluorouracil or 5-FU (trademarked as Adrucil(IV), Carac (topical), Efudex and Efudix (topical)) is a drug that is a pyrimidine analog which is used in the treatment of cancer. It is a suicide inhibitor and works through irreversible inhibition ofthymidylate synthase. It belongs to the family of drugs called the antimetabolites.

It is on the World Health Organization's List of Essential Medicines, a list of the most important medications needed in a basic health system.

5-Fluorouracil (5-FU) is widely used in the treatment of cancer. Over the past 20 years, increased understanding of the mechanism of action of 5-FU has led to the development of strategies that increase its anticancer activity. Despite these advances, drug resistance remains a significant limitation to the clinical use of 5-FU. Emerging technologies, such as DNA microarray profiling, have the potential to identify novel genes that are involved in mediating resistance to 5-FU. Such target genes might prove to be therapeutically valuable as new targets for chemotherapy, or as predictive biomarkers of response to 5-FU-based chemotherapy.

Usage:

Fluorouracil (CAS NO.51-21-8) can be used in against cancer for about 40 years, acts in several ways, but principally as a thymidylate synthase inhibitor. It can be used in colorectal cancer and pancreatic cancer,also it can be used for treating actinic (solar) keratoses and some types of basal cell carcinomas of the skin.

Fluorouracil has been given systemically for anal, breast, colorectal,oesophageal, stomach, pancreatic and skin cancers (especially head and neck cancers). It has also been given topically for actinic keratoses, skin cancers and Bowen's disease.